We provide a turn-key process to appeal out-of-network claims. Claims that have been processed but paid less than your billed charges are eligible for a legal appeal under federal and state law. MedCapp uses a legal algorithm and claim specialists to appeal claims directly to the payor and/or plan administrators using proven strategies.
Contingency pricing is available with a no-risk guarantee to collect more on claims that would otherwise not result in any additional payment. MedCapp ensures your appeal (i) collects more, (ii) sets the legal record straight, and (iii) exhausts the administrative process.
Federal (ERISA) & State Law
Based Appeal Process
MedCapp appeals claims based on applicable federal and/or state law. Any claim that pays less than billed charges is considered an adverse benefit determination and is eligible for an appeal for ERISA-governed plans. The first dollar paid in a provider's revenue cycle management is the easiest to collect, but the last dollar is the hardest. By utilizing the tools the law gives providers to appeal health claims, MedCapp makes collecting that last dollar just as easy as the first.
In addition to the typical denial management cycles that all providers must address with payors, out-of-network providers have the additional burden of not having a prenegotiated rate that it is entitled to be reimbursed; instead, providers must rely on the payors to follow the terms of their plans on the level of reimbursement. Unfortunately, many payors fail to do so. MedCapp holds payors to the terms of their plans and challenges their reimbursement methodology with the objective of collecting more.
ERISA (Employee Retirement Income Security Act) governs self-funded insurance plans, with few exceptions. ERISA provides for a very specific appeals process that MedCapp utilizes for many of its claims recovery processes. MedCapp implements a robust ERISA-based appeals process with three objectives: (i) collect more, (ii) exhaust the administrative appeals process, and (iii) establish a clear administraive record for further judicial review.
CARES Act generally requires plans and issuers providing coverage for the items and services described in section 6001(a) of the FFCRA to reimburse any provider of COVID-19 diagnostic testing an amount that equals the negotiated rate or, if the plan or issuer does not have a negotiated rate with the provider, the cash price for such service that is listed by the provider on its public website.